Skip to content

Clinical trials

Phase 3 Cystic Fibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cystic Fibrosis Phase: Phase 3 Clear all

154 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20032
20057
20065
20078
200810
200913
201013
20114
20128
20138
20144
201510
20166
201710
201811
20195
20206
20215
20226
20232
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed129
Terminated11
Active, not recruiting5
Unknown status4
Withdrawn3
Recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Vertex Pharmaceuticals Incorporated62
Gilead Sciences9
Forest Laboratories6
Anthera Pharmaceuticals5
Novartis Pharmaceuticals5
PTC Therapeutics5
Insmed Incorporated3
Merck Sharp & Dohme LLC3
Solvay Pharmaceuticals3
Syntara3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cystic Fibrosis154
Exocrine Pancreatic Insufficiency17
Pseudomonas Infections10
Lung Diseases9
Diabetes Mellitus5
Respiratory Tract Diseases5
Genetic Diseases, Inborn4
Inflammation4
Respiratory Tract Infections4
Steatorrhea4

Trials

Showing 1 to 25 of 154. Each trial links to its page on Pharma Observatory.

54 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.